Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2022 | Real-world treatment outcomes of amivantamab in pre-approval access (PAA) participants with advanced non-small cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations (ex20ins) | ANNALS OF ONCOLOGY |